Gene Details



GNAI3 and homologs in 4 species are found in 603 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS204122: GO:0031279 regulation of cyclase activity
GS199582: GO:0016044 cellular membrane organization
GS204629: GO:1901564 organonitrogen compound metabolic process
GS197668: GO:0051241 negative regulation of multicellular organismal process
GS185985: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GS205510: GO:0001883 purine nucleoside binding
GS200192: GO:0005834 heterotrimeric G-protein complex
GS171644: HP:0011842 Abnormality of skeletal morphology
GS121514: Paraquat interacting genes (MeSH:D010269) in CTD
GS178396: GO:0016050 vesicle organization
GS189855: GO:0043168 anion binding
GS168559: MP:0002421 abnormal cell-mediated immunity
GS190997: GO:0044281 small molecule metabolic process
GS199701: GO:0003924 GTPase activity
GS172261: HP:0000357 Abnormal location of ears
GS174134: HP:0002012 Abnormality of the abdominal organs
GS184984: GO:0032553 ribonucleotide binding
GS201052: GO:0061024 membrane organization
GS183645: GO:0017076 purine nucleotide binding
GS196934: GO:0065008 regulation of biological quality
GS1229: Differential gene expression among both the Heroin and Cocaine Abusers
GS194391: GO:0006164 purine nucleotide biosynthetic process
GS171596: HP:0000164 Abnormality of the teeth
GS173284: HP:0000311 Round face
GS167747: MP:0008560 increased tumor necrosis factor secretion
GS176151: HP:0000256 Macrocephaly
GS195083: GO:0007267 cell-cell signaling
GS123134: Forskolin interacting genes (MeSH:D005576) in CTD
GS170969: HP:0000157 Abnormality of the tongue
GS198188: GO:1900371 regulation of purine nucleotide biosynthetic process
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS170860: HP:0008537 Cleft at the superior portion of the pinna
GS181170: GO:0006944 cellular membrane fusion
GS196555: GO:0051339 regulation of lyase activity
GS176107: HP:0000929 Abnormality of the skull
GS191088: GO:0009199 ribonucleoside triphosphate metabolic process
GS187854: GO:0030496 midbody
GS209042: GO:0043086 negative regulation of catalytic activity
GS180134: GO:0046128 purine ribonucleoside metabolic process
GS207857: GO:0009058 biosynthetic process
GS192986: GO:0006996 organelle organization
GS204630: GO:1901565 organonitrogen compound catabolic process
GS192279: GO:0007166 cell surface receptor signaling pathway
GS192691: GO:0015630 microtubule cytoskeleton
GS189350: GO:0042454 ribonucleoside catabolic process
GS192672: GO:0055086 nucleobase-containing small molecule metabolic process
GS201023: GO:0071704 organic substance metabolic process
GS180122: GO:0009203 ribonucleoside triphosphate catabolic process
GS84151: METH responses for body temperature (Published QTL, Chr 3)
GS176033: HP:0011039 Abnormality of the helix
GS201737: GO:0007596 blood coagulation
GS201132: GO:0010646 regulation of cell communication
GS192017: GO:0006139 nucleobase-containing compound metabolic process
GS196343: GO:0036094 small molecule binding
GS197959: GO:0006944 cellular membrane fusion
GS170964: HP:0000152 Abnormality of head and neck
GS180276: GO:0006195 purine nucleotide catabolic process
GS191106: GO:0044464 cell part
GS191379: GO:0005815 microtubule organizing center
GS210137: GO:0016462 pyrophosphatase activity
GS177404: GO:0005737 cytoplasm
GS177570: GO:0016043 cellular component organization
GS208893: GO:0005856 cytoskeleton
GS210436: GO:0072522 purine-containing compound biosynthetic process
GS201251: GO:0044424 intracellular part
GS136876: T cell ratio modifier QTL 6 (Trmq6, Published QTL Chr 3)
GS165136: MP:0003009 abnormal cytokine secretion
GS194737: GO:0030168 platelet activation
GS178359: GO:0071840 cellular component organization or biogenesis
GS209401: GO:0046130 purine ribonucleoside catabolic process
GS198972: GO:0006152 purine nucleoside catabolic process
GS204612: GO:0019222 regulation of metabolic process
GS181533: GO:0046872 metal ion binding
GS196894: GO:0009207 purine ribonucleoside triphosphate catabolic process
GS136207: liver iron content 2 (Lvic2, Published QTL Chr 3)
GS183543: GO:0051179 localization
GS136913: vertebral morphology and mechanical traits 18 (Vmmt18, Published QTL Chr 3)
GS178909: GO:0017111 nucleoside-triphosphatase activity
GS178357: GO:0071842 cellular component organization at cellular level
GS177311: GO:1901361 organic cyclic compound catabolic process
GS177737: GO:0019897 extrinsic to plasma membrane
GS177800: GO:0042588 zymogen granule
GS136473: periosteal circumference and femur length 3 (Pcfm3, Published QTL Chr 3)
GS205500: GO:0071944 cell periphery
GS135909: G protein deficiency-induced colitis 1 (Gpdc1, Published QTL Chr 3)
GS199417: GO:1901069 guanosine-containing compound catabolic process
GS203483: GO:0044092 negative regulation of molecular function
GS209108: GO:0000166 nucleotide binding
GS124659: Metribolone interacting genes (MeSH:D015741) in CTD
GS135335: atherosclerotic lesion area 4 (Ascla4, Published QTL Chr 3)
GS174066: HP:0100737 Abnormality of the hard palate
GS169133: MP:0002442 abnormal leukocyte physiology
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
GS192074: GO:1901575 organic substance catabolic process
GS180118: GO:0009207 purine ribonucleoside triphosphate catabolic process
GS195146: GO:0016050 vesicle organization
GS171011: HP:0009088 Speech articulation difficulties
GS203608: GO:0034655 nucleobase-containing compound catabolic process
GS181721: GO:0006163 purine nucleotide metabolic process
GS177565: GO:0009166 nucleotide catabolic process
GS188652: GO:0001882 nucleoside binding
GS176615: HP:0000277 Abnormality of the mandible
GS185585: GO:0044710 single-organism metabolic process
GS177567: GO:0009164 nucleoside catabolic process
GS204106: GO:0060089 molecular transducer activity
GS173137: HP:0011821 Abnormality of facial skeleton
GS206726: GO:0009261 ribonucleotide catabolic process
GS206616: GO:0007187 G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
GS208978: GO:0043169 cation binding
GS175601: HP:0002086 Abnormality of the respiratory system
GS203266: GO:0006140 regulation of nucleotide metabolic process
GS198897: GO:0052652 cyclic purine nucleotide metabolic process
GS201799: GO:0032550 purine ribonucleoside binding
GS201800: GO:0032553 ribonucleotide binding
GS203019: GO:0045934 negative regulation of nucleobase-containing compound metabolic process
GS171564: HP:0000383 Abnormality of periauricular region
GS182900: GO:0003924 GTPase activity
GS189743: GO:0007186 G-protein coupled receptor signaling pathway
GS207614: GO:0016023 cytoplasmic membrane-bounded vesicle
GS194455: GO:0051239 regulation of multicellular organismal process
GS201051: GO:0061025 membrane fusion
GS206354: GO:0023057 negative regulation of signaling
GS178426: GO:0005102 receptor binding
GS166548: MP:0008661 decreased interleukin-10 secretion
GS188651: GO:0001883 purine nucleoside binding
GS136353: novelty/stress induced locomotor activation 3 (Nsila3, Published QTL Chr 3)
GS194542: GO:0042588 zymogen granule
GS197892: GO:0043228 non-membrane-bounded organelle
GS199854: GO:0019001 guanyl nucleotide binding
GS192256: GO:0007049 cell cycle
GS192615: GO:0031988 membrane-bounded vesicle
GS189484: GO:0023052 signaling
GS175982: HP:0000162 Glossoptosis
GS86977: Table S1: All transcripts significantly different in abundance between the majority of heroin subjects and their matched controls [DRG] provisional
GS192299: GO:0006793 phosphorus metabolic process
GS209928: GO:0006996 organelle organization
GS196808: GO:0032501 multicellular organismal process
GS178401: GO:0019637 organophosphate metabolic process
GS186744: GO:0043226 organelle
GS198782: GO:0044459 plasma membrane part
GS202715: GO:0035637 multicellular organismal signaling
GS182835: GO:0005622 intracellular
GS202415: GO:0044710 single-organism metabolic process
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
GS207903: GO:0044281 small molecule metabolic process
GS207995: GO:0009199 ribonucleoside triphosphate metabolic process
GS198684: GO:0048523 negative regulation of cellular process
GS177743: GO:0019898 extrinsic to membrane
GS194133: GO:0005737 cytoplasm
GS165474: MP:0002723 abnormal immune serum protein physiology
GS136292: modifier of obesity related sterility 2 (Mors2, Published QTL Chr 3)
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS136808: tuberculosis severity 1 (Tbs1, Published QTL Chr 3)
GS191375: GO:0005813 centrosome
GS207389: GO:0009150 purine ribonucleotide metabolic process
GS196843: GO:0045761 regulation of adenylate cyclase activity
GS194111: GO:0097159 organic cyclic compound binding
GS189860: GO:0043167 ion binding
GS176642: HP:0011355 Localized skin lesion
GS191129: GO:0016787 hydrolase activity
GS204150: GO:0009611 response to wounding
GS184448: GO:0044425 membrane part
GS204054: GO:0044057 regulation of system process
GS191196: GO:0031234 extrinsic to internal side of plasma membrane
GS209634: GO:0015630 microtubule cytoskeleton
GS194307: GO:0016043 cellular component organization
GS190712: GO:0016023 cytoplasmic membrane-bounded vesicle
GS172572: HP:0000347 Micrognathia
GS200341: GO:0051179 localization
GS206742: GO:0043167 ion binding
GS171790: HP:0000372 Abnormality of the auditory canal
GS206781: GO:0009116 nucleoside metabolic process
GS174150: HP:0007628 Mandibular condyle hypoplasia
GS202828: GO:0016817 hydrolase activity, acting on acid anhydrides
GS184463: GO:0009898 internal side of plasma membrane
GS189751: GO:0050794 regulation of cellular process
GS182325: GO:0051716 cellular response to stimulus
GS186162: GO:0006906 vesicle fusion
GS195082: GO:0007268 synaptic transmission
GS177557: GO:0048284 organelle fusion
GS199286: GO:0046058 cAMP metabolic process
GS202890: GO:0030814 regulation of cAMP metabolic process
GS209010: GO:1901575 organic substance catabolic process
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
GS184244: GO:0061024 membrane organization
GS171815: HP:0001574 Abnormality of the integument
GS185492: GO:0050789 regulation of biological process
GS194302: GO:0009166 nucleotide catabolic process
GS186238: GO:0009144 purine nucleoside triphosphate metabolic process
GS181473: GO:0005488 binding
GS175526: HP:0000005 Mode of inheritance
GS203000: GO:0006906 vesicle fusion
GS175823: HP:0002093 Respiratory insufficiency
GS172593: HP:0010609 Skin tags
GS196930: GO:0065007 biological regulation
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS192512: GO:0003824 catalytic activity
GS192609: GO:0031982 vesicle
GS180644: GO:0032549 ribonucleoside binding
GS207616: GO:0016020 membrane
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
GS175979: HP:0009115 Aplasia/Hypoplasia involving the skeleton
GS180229: GO:0005886 plasma membrane
GS182665: GO:0042278 purine nucleoside metabolic process
GS189896: GO:0009117 nucleotide metabolic process
GS128040: Alcohol consumption QTL 15 (Alc15, Published QTL, Chr 2)
GS198502: GO:0050804 regulation of synaptic transmission
GS167542: MP:0001790 abnormal immune system physiology
GS181666: GO:0019439 aromatic compound catabolic process
GS203058: GO:0048519 negative regulation of biological process
GS204746: GO:0080090 regulation of primary metabolic process
GS205321: GO:0031410 cytoplasmic vesicle
GS204610: GO:0019220 regulation of phosphate metabolic process
GS197244: GO:0044237 cellular metabolic process
GS201264: GO:0009890 negative regulation of biosynthetic process
GS176029: HP:0009116 Aplasia/Hypoplasia involving bones of the skull
GS198456: GO:0019438 aromatic compound biosynthetic process
GS173949: HP:0008589 Hypoplastic helices
GS203021: GO:0045936 negative regulation of phosphate metabolic process
GS175529: HP:0000001 All
GS209199: GO:0007165 signal transduction
GS174135: HP:0002015 Dysphagia
GS188962: GO:1901292 nucleoside phosphate catabolic process
GS198323: GO:0046872 metal ion binding
GS199459: GO:0042278 purine nucleoside metabolic process
GS201262: GO:0009892 negative regulation of metabolic process
GS175527: HP:0000006 Autosomal dominant inheritance
GS194482: GO:0019898 extrinsic to membrane
GS136031: induction of brown adipocytes 2 (Iba2, Published QTL Chr 3)
GS202889: GO:0030817 regulation of cAMP biosynthetic process
GS184447: GO:0044424 intracellular part
GS189897: GO:0009116 nucleoside metabolic process
GS206737: GO:0043168 anion binding
GS207862: GO:0009056 catabolic process
GS198455: GO:0019439 aromatic compound catabolic process
GS171394: HP:0000174 Abnormality of the palate
GS183592: GO:0032561 guanyl ribonucleotide binding
GS171593: HP:0000160 Narrow mouth
GS193489: GO:0072521 purine-containing compound metabolic process
GS209863: GO:0050896 response to stimulus
GS210435: GO:0072521 purine-containing compound metabolic process
GS201538: GO:0030799 regulation of cyclic nucleotide metabolic process
GS206356: GO:0023051 regulation of signaling
GS126434: Chlorpyrifos interacting genes (MeSH:D004390) in CTD
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
GS210437: GO:0072523 purine-containing compound catabolic process
GS186740: GO:0043229 intracellular organelle
GS198012: GO:0046434 organophosphate catabolic process
GS136875: T cell ratio modifier QTL 5 (Trmq5, Published QTL Chr 3)
GS175825: HP:0002094 Dyspnea
GS191700: GO:0006753 nucleoside phosphate metabolic process
GS135954: HDL QTL 21 (Hdlq21, Published QTL Chr 3)
GS171520: HP:0004453 Overfolding of the superior helices
GS172288: HP:0000358 Posteriorly rotated ears
GS170966: HP:0000402 Stenosis of the external auditory canal
GS206052: GO:0031683 G-protein beta/gamma-subunit complex binding
GS208012: GO:0044464 cell part
GS201252: GO:0044425 membrane part
GS210212: GO:0005575 cellular_component
GS201239: GO:0046483 heterocycle metabolic process
GS197630: GO:0001664 G-protein coupled receptor binding
GS177334: GO:0016192 vesicle-mediated transport
GS188399: GO:0044238 primary metabolic process
GS206623: GO:0050794 regulation of cellular process
GS171224: HP:0004451 Postauricular skin tag
GS184435: GO:0046483 heterocycle metabolic process
GS194101: GO:0050817 coagulation
GS205825: GO:1901292 nucleoside phosphate catabolic process
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
GS174148: HP:0007627 Mandibular condyle aplasia
GS184243: GO:0061025 membrane fusion
GS179580: GO:0036094 small molecule binding
GS206714: GO:0030800 negative regulation of cyclic nucleotide metabolic process
GS194038: GO:1901362 organic cyclic compound biosynthetic process
GS210472: GO:1901068 guanosine-containing compound metabolic process
GS176101: HP:0000924 Abnormality of the skeletal system
GS172033: HP:0000369 Low-set ears
GS135379: bone density traits 2 (Bdt2, Published QTL Chr 3)
GS190492: GO:0009154 purine ribonucleotide catabolic process
GS201019: GO:0046039 GTP metabolic process
GS174385: HP:0002088 Abnormality of the lung
GS174500: HP:0000707 Abnormality of the nervous system
GS177310: GO:1901360 organic cyclic compound metabolic process
GS196896: GO:0009205 purine ribonucleoside triphosphate metabolic process
GS206615: GO:0007186 G-protein coupled receptor signaling pathway
GS201267: GO:0009898 internal side of plasma membrane
GS210180: GO:0031326 regulation of cellular biosynthetic process
GS126265: Diazinon interacting genes (MeSH:D003976) in CTD
GS203509: GO:0030141 secretory granule
GS185236: GO:0006184 GTP catabolic process
GS182834: GO:0005623 cell
GS204285: GO:0031645 negative regulation of neurological system process
GS205622: GO:0009889 regulation of biosynthetic process
GS205511: GO:0001882 nucleoside binding
GS163667: MP:0008568 abnormal interleukin secretion
GS199591: GO:0042060 wound healing
GS197016: GO:0032991 macromolecular complex
GS135456: bone marrow pre-B 1 (Bomb1, Published QTL Chr 3)
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
GS199635: GO:0005622 intracellular
GS193527: GO:1901068 guanosine-containing compound metabolic process
GS135317: alcohol preference 6 QTL (Ap6q, Published QTL Chr 3)
GS194304: GO:0009164 nucleoside catabolic process
GS128625: Alcohol response QTL 17 (Alcrsp17 Published QTL Chr 2)
GS176038: HP:0002795 Functional respiratory abnormality
GS196912: GO:0046128 purine ribonucleoside metabolic process
GS203085: GO:0009146 purine nucleoside triphosphate catabolic process
GS186758: GO:0034655 nucleobase-containing compound catabolic process
GS196943: GO:0008152 metabolic process
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
GS187146: GO:0044700 single organism signaling
GS209550: GO:0031982 vesicle
GS201733: GO:0007599 hemostasis
GS174075: HP:0009121 Abnormal axial skeleton morphology
GS196941: GO:0008150 biological_process
GS199634: GO:0005623 cell
GS208298: GO:0005813 centrosome
GS123026: Haloperidol interacting genes (MeSH:D006220) in CTD
GS164136: MP:0000001 mammalian phenotype
GS204029: GO:0010648 negative regulation of cell communication
GS198663: GO:0051301 cell division
GS207680: GO:0051969 regulation of transmission of nerve impulse
GS197009: GO:0005886 plasma membrane
GS205826: GO:1901293 nucleoside phosphate biosynthetic process
GS201256: GO:0044422 organelle part
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
GS204007: GO:0044700 single organism signaling
GS182622: GO:1901069 guanosine-containing compound catabolic process
GS189900: GO:0009119 ribonucleoside metabolic process
GS210182: GO:0031323 regulation of cellular metabolic process
GS173563: HP:0000692 Misalignment of teeth
GS201431: GO:0005515 protein binding
GS173743: HP:0001999 Abnormal facial shape
GS176613: HP:0000271 Abnormality of the face
GS175928: HP:0000240 Abnormality of skull size
GS196933: GO:0065009 regulation of molecular function
GS187247: GO:0060089 molecular transducer activity
GS180838: GO:0001664 G-protein coupled receptor binding
GS191954: GO:0005856 cytoskeleton
GS199267: GO:0043234 protein complex
GS174579: HP:0002031 Abnormality of the esophagus
GS195110: GO:0071842 cellular component organization at cellular level
GS193059: GO:0044446 intracellular organelle part
GS203377: GO:0051970 negative regulation of transmission of nerve impulse
GS168560: MP:0002420 abnormal adaptive immunity
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS194504: GO:1901136 carbohydrate derivative catabolic process
GS183053: GO:0019001 guanyl nucleotide binding
GS206620: GO:0050790 regulation of catalytic activity
GS194293: GO:0048284 organelle fusion
GS136694: systematic lupus erythematosus susceptibility 11 (Sle11, Published QTL Chr 3)
GS210179: GO:0031327 negative regulation of cellular biosynthetic process
GS169827: MP:0005387 immune system phenotype
GS176585: HP:0005790 Short mandibular condyles
GS198511: GO:0006163 purine nucleotide metabolic process
GS163853: MP:0001547 abnormal lipid level
GS175981: HP:0000163 Abnormality of the oral cavity
GS190496: GO:0009150 purine ribonucleotide metabolic process
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
GS196898: GO:0009203 ribonucleoside triphosphate catabolic process
GS206215: GO:0042454 ribonucleoside catabolic process
GS171428: HP:0003778 Short mandibular rami
GS209452: GO:0006810 transport
GS204608: GO:0019226 transmission of nerve impulse
GS136754: susceptibility to Salmonella typhimurium antigens 5 (Ssta5, Published QTL Chr 3)
GS174606: HP:0001608 Abnormality of the voice
GS171848: HP:0000598 Abnormality of the ear
GS207385: GO:0009154 purine ribonucleotide catabolic process
GS136532: pristane induced arthritis 1 (Prtia1, Published QTL Chr 3)
GS171395: HP:0000175 Cleft palate
GS187876: GO:0045121 membrane raft
GS194118: GO:0007193 adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS184629: GO:0005515 protein binding
GS206692: GO:0030809 negative regulation of nucleotide biosynthetic process
GS208636: GO:0006753 nucleoside phosphate metabolic process
GS187770: GO:1901565 organonitrogen compound catabolic process
GS189767: GO:0031821 G-protein coupled serotonin receptor binding
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
GS199500: GO:0051172 negative regulation of nitrogen compound metabolic process
GS194459: GO:0051234 establishment of localization
GS179211: GO:0007154 cell communication
GS188465: GO:0031410 cytoplasmic vesicle
GS192265: GO:0007165 signal transduction
GS84150: ethanol conditioned taste aversion (Published QTL, Chr 3)
GS180152: GO:0065007 biological regulation
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
GS202886: GO:0030818 negative regulation of cAMP biosynthetic process
GS198501: GO:0050805 negative regulation of synaptic transmission
GS203328: GO:0007188 adenylate cyclase-modulating G-protein coupled receptor signaling pathway
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
GS136945: white blood cell quantitative locus 2 (Wbcq2, Published QTL Chr 3)
GS202760: GO:0004871 signal transducer activity
GS185366: GO:0044248 cellular catabolic process
GS194041: GO:1901361 organic cyclic compound catabolic process
GS136570: radiation induced acute myeloid leukemia 2 (Raml2, Published QTL Chr 3)
GS206197: GO:0045980 negative regulation of nucleotide metabolic process
GS194119: GO:0007194 negative regulation of adenylate cyclase activity
GS173337: HP:0000689 Dental malocclusion
GS202899: GO:0050877 neurological system process
GS205180: GO:0005525 GTP binding
GS136810: total cholesterol level 1 (Tchol1, Published QTL Chr 3)
GS175602: HP:0002087 Abnormality of the upper respiratory tract
GS192461: GO:0046130 purine ribonucleoside catabolic process
GS201002: GO:0044270 cellular nitrogen compound catabolic process
GS182175: GO:0006152 purine nucleoside catabolic process
GS200181: GO:1900543 negative regulation of purine nucleotide metabolic process
GS201075: GO:0005794 Golgi apparatus
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
GS203654: GO:0009187 cyclic nucleotide metabolic process
GS184214: GO:0046039 GTP metabolic process
GS187633: GO:0019693 ribose phosphate metabolic process
GS207282: GO:0031324 negative regulation of cellular metabolic process
GS170965: HP:0000153 Abnormality of the mouth
GS203594: GO:0043226 organelle
GS195665: GO:0017111 nucleoside-triphosphatase activity
GS174879: HP:0002104 Apnea
GS208000: GO:0009190 cyclic nucleotide biosynthetic process
GS200446: GO:0017076 purine nucleotide binding
GS203082: GO:0009143 nucleoside triphosphate catabolic process
GS206639: GO:0031821 G-protein coupled serotonin receptor binding
GS210002: GO:0044444 cytoplasmic part
GS171168: HP:0000234 Abnormality of the head
GS193491: GO:0072523 purine-containing compound catabolic process
GS209009: GO:1901576 organic substance biosynthetic process
GS184983: GO:0032550 purine ribonucleoside binding
GS165537: MP:0005376 homeostasis/metabolism phenotype
GS181872: GO:0051301 cell division
GS181988: GO:0044459 plasma membrane part
GS209960: GO:0003008 system process
GS186235: GO:0009141 nucleoside triphosphate metabolic process
GS201392: GO:1900372 negative regulation of purine nucleotide biosynthetic process
GS184198: GO:0044270 cellular nitrogen compound catabolic process
GS192174: GO:0000166 nucleotide binding
GS203593: GO:0043227 membrane-bounded organelle
GS181102: GO:0043228 non-membrane-bounded organelle
GS191973: GO:0046700 heterocycle catabolic process
GS200182: GO:1900542 regulation of purine nucleotide metabolic process
GS194505: GO:1901135 carbohydrate derivative metabolic process
GS135581: cystic fibrosis survival to weaning 1 (Cfsw1, Published QTL Chr 3)
GS209614: GO:0055086 nucleobase-containing small molecule metabolic process
GS210000: GO:0044446 intracellular organelle part
GS163306: MP:0008556 abnormal tumor necrosis factor secretion
GS194605: GO:0001775 cell activation
GS202316: GO:0050789 regulation of biological process
GS208810: GO:0009259 ribonucleotide metabolic process
GS194087: GO:0003674 molecular_function
GS204713: GO:0030496 midbody
GS171793: HP:0000377 Abnormality of the pinna
GS167098: MP:0001819 abnormal immune cell physiology
GS177356: GO:0003674 molecular_function
GS203590: GO:0043229 intracellular organelle
GS126638: biochanin A interacting genes (MeSH:C004541) in CTD
GS136494: proteoglycan induced arthritis 26 (Pgia26, Published QTL Chr 3)
GS207143: GO:0032403 protein complex binding
GS167321: MP:0003945 abnormal lymphocyte physiology
GS177309: GO:1901363 heterocyclic compound binding
GS169128: MP:0002444 abnormal T cell physiology
GS202057: GO:0006184 GTP catabolic process
GS180166: GO:0008152 metabolic process
GS129113: collagen induced arthritis 22 (Cia22 Published QTL Chr 3)
GS203083: GO:0009144 purine nucleoside triphosphate metabolic process
GS171832: HP:0000118 Phenotypic abnormality
GS183398: GO:0005834 heterotrimeric G-protein complex
GS203886: GO:1901265 nucleoside phosphate binding
GS165133: MP:0008659 abnormal interleukin-10 secretion
GS184267: GO:0005794 Golgi apparatus
GS204631: GO:1901566 organonitrogen compound biosynthetic process
GS136312: Nakano cataract modifier 1 (nctm1, Published QTL Chr 3)
GS136393: organ weight 2 (Org2, Published QTL Chr 3)
GS177382: GO:0097159 organic cyclic compound binding
GS174076: HP:0009122 Aplasia/Hypoplasia affecting bones of the axial skeleton
GS192509: GO:0006810 transport
GS135561: cytokine deficiency colitis susceptibility 1 (Cdcs1, Published QTL Chr 3)
GS189844: GO:0009261 ribonucleotide catabolic process
GS184978: GO:0032555 purine ribonucleotide binding
GS202891: GO:0030815 negative regulation of cAMP metabolic process
GS209190: GO:0007049 cell cycle
GS125960: Cholecalciferol interacting genes (MeSH:D002762) in CTD
GS167433: MP:0009818 abnormal thromboxane level
GS194065: GO:0016192 vesicle-mediated transport
GS194476: GO:0019897 extrinsic to plasma membrane
GS194305: GO:0009165 nucleotide biosynthetic process
GS177766: GO:1901135 carbohydrate derivative metabolic process
GS190714: GO:0016020 membrane
GS186237: GO:0009143 nucleoside triphosphate catabolic process
GS195214: GO:0009987 cellular process
GS206784: GO:0009119 ribonucleoside metabolic process
GS163934: MP:0001764 abnormal homeostasis
GS184452: GO:0044422 organelle part
GS188323: GO:0005525 GTP binding
GS193193: GO:0016462 pyrophosphatase activity
GS195112: GO:0071840 cellular component organization or biogenesis
GS199124: GO:0051716 cellular response to stimulus
GS171563: HP:0000384 Preauricular skin tag
GS201794: GO:0032555 purine ribonucleotide binding
GS208110: GO:0031234 extrinsic to internal side of plasma membrane
GS171369: HP:0000396 Overfolded helix
GS203712: GO:0051350 negative regulation of lyase activity
GS128160: Hippocampus Methamphetamine and reward
GS174126: HP:0009902 Cleft helix
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS135674: cholesterol QTL 3 (Cq3, Published QTL Chr 3)
GS199495: GO:0051174 regulation of phosphorus metabolic process
GS207165: GO:0030808 regulation of nucleotide biosynthetic process
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS187023: GO:1901265 nucleoside phosphate binding
GS171607: HP:0011337 Abnormality of mouth size
GS135760: experimental allergic encephalomyelitis susceptibility 3 (Eae3, Published QTL Chr 3)
GS192296: GO:0006796 phosphate-containing compound metabolic process
GS198263: GO:0005488 binding
GS194040: GO:1901360 organic cyclic compound metabolic process
GS206355: GO:0023052 signaling
GS192918: GO:0050896 response to stimulus
GS177765: GO:1901136 carbohydrate derivative catabolic process
GS195151: GO:0019637 organophosphate metabolic process
GS122653: Clozapine interacting genes (MeSH:D003024) in CTD
GS191870: GO:0009259 ribonucleotide metabolic process
GS84149: alcohol preference 6 QTL (Ap6q, Published QTL, Chr 3)
GS208037: GO:0016787 hydrolase activity
GS209075: GO:0031280 negative regulation of cyclase activity
GS173096: HP:0000678 Dental crowding
GS209235: GO:0006793 phosphorus metabolic process
GS195977: GO:0007154 cell communication
GS204496: GO:0019693 ribose phosphate metabolic process
GS206205: GO:0006171 cAMP biosynthetic process
GS180120: GO:0009205 purine ribonucleoside triphosphate metabolic process
GS174516: HP:0008559 Hypoplastic superior helix
GS208302: GO:0005815 microtubule organizing center
GS210357: GO:0044249 cellular biosynthetic process
GS180452: GO:0044237 cellular metabolic process
GS204735: GO:0045121 membrane raft
GS207170: GO:0030803 negative regulation of cyclic nucleotide biosynthetic process
GS129124: C. trachomatis resistance QTL 2 (Ctrq2 Published QTL Chr 3)
GS182469: GO:0043234 protein complex
GS206953: GO:0018130 heterocycle biosynthetic process
GS135930: hematocrit QTL 1 (Hctq1, Published QTL Chr 3)
GS188751: GO:0044430 cytoskeletal part
GS174453: HP:0001438 Abnormality of the abdomen
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
GS180164: GO:0008150 biological_process
GS136803: tibia bone quality traits 4 (Tbqt4, Published QTL Chr 3)
GS202897: GO:0050878 regulation of body fluid levels
GS203080: GO:0009141 nucleoside triphosphate metabolic process
GS194460: GO:0090407 organophosphate biosynthetic process
GS209555: GO:0031988 membrane-bounded vesicle
GS207171: GO:0030802 regulation of cyclic nucleotide biosynthetic process
GS205255: GO:0044238 primary metabolic process
GS180236: GO:0032991 macromolecular complex
GS185921: GO:0004871 signal transducer activity
GS187769: GO:1901564 organonitrogen compound metabolic process
GS206780: GO:0009117 nucleotide metabolic process
GS172260: HP:0000356 Abnormality of the outer ear
GS209232: GO:0006796 phosphate-containing compound metabolic process
GS177721: GO:0051234 establishment of localization
GS195176: GO:0005102 receptor binding
GS190954: GO:0009056 catabolic process
GS182784: GO:0016044 cellular membrane organization
GS209455: GO:0003824 catalytic activity
GS184218: GO:0071704 organic substance metabolic process
GS135517: body weight QTL 8 (Bwq8, Published QTL Chr 3)
GS195595: GO:0010563 negative regulation of phosphorus metabolic process
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GS176169: HP:0009102 Anterior open-bite malocclusion
GS176826: HP:0000202 Oral cleft
GS174646: HP:0000951 Abnormality of the skin
GS166412: MP:0002118 abnormal lipid homeostasis
GS135591: P. chabaudi malaria resistance QTL 4 (Char4, Published QTL Chr 3)
GS173583: HP:0008544 Abnormally folded helix
GS201949: GO:0044699 single-organism process
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS188641: GO:0071944 cell periphery
GS175900: HP:0009118 Aplasia/Hypoplasia of the mandible
GS181223: GO:0046434 organophosphate catabolic process
GS178461: GO:0009987 cellular process
GS193061: GO:0044444 cytoplasmic part
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS200393: GO:0032561 guanyl ribonucleotide binding
GS204284: GO:0031644 regulation of neurological system process
GS186743: GO:0043227 membrane-bounded organelle
GS208912: GO:0046700 heterocycle catabolic process
GS186662: GO:0030141 secretory granule
GS192041: GO:0043169 cation binding
GS210507: GO:0006950 response to stress
GS186240: GO:0009146 purine nucleoside triphosphate catabolic process
GS197054: GO:0006195 purine nucleotide catabolic process
GS174612: HP:0001600 Abnormality of the larynx
GS175510: HP:0005216 Chewing difficulties
GS193268: GO:0005575 cellular_component
GS194039: GO:1901363 heterocyclic compound binding
GS1250: High-density microarray analysis of hippocampal gene expression following experimental brain injury
GS188190: GO:0006807 nitrogen compound metabolic process
GS209215: GO:0007166 cell surface receptor signaling pathway
GS136851: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 2 (Tmevd2, Published QTL Chr 3)
GS171795: HP:0000378 Cupped ear
GS197443: GO:0032549 ribonucleoside binding
GS128572: Ethanol Induced Hypothermia Chr# 3
GS202188: GO:0044248 cellular catabolic process
GS205610: GO:0044430 cytoskeletal part